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Background: Hepatic epithelioid hemangioendothelioma (PHEHEl is a multifocal. low-
grade malignant neoplasia characterized by its epithelial-like appearance and vascular en-
dothelial histogenesis. The outcome of 16 patients treated with orthotopic liver transplan-
tation (OL T) is the subject of this report. 
Methods: A retrospective study of 16 patients with HEHE (7 men. 9 women) with ages 
ranging from 24 to 58 years (mean 37 :!: 10.6 years). Follow-up intervals ranged from I to 
15 years (median of 4.5 \ ears). 
Results: Actual patieni survival at 1. 3. and 5 years was 100. 87.5. and 7\.3%, respec-
tively. Disease-free survival at 1,3. and 5 years was 81.3. 68.8, and 60.2%. respectively. 
The 90-day operative mortality was O. Involvement of the hilar lymph nodes or vascular 
invasion did not affect survival. The 5-year survival of HEHE compares favorably with 
that of hepatocellular carcinoma at the same stage (stage 4A): 71.3 versus 9.8% (p = 0.001) 
Conclusions: The long-term survival obtained in this series justifies OL T for these tumors 
even in the presence of limited extrahepatic disease. 
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Epithelioid hemangioendothelioma (EHE) is a 
low-grade malignant neoplasm derived from endo-
thelial cells. It was first recognized in soft tissues 
(1). with later reports showing that the liver may 
also serve as a primary site (2). We have treated 16 
cases of primary hepatic EHE with orthotopic liver 
transplantation (OLTl. and they are the subject of 
this report. 
MATERL-\LS AND METHODS 
Patient profile 
Between November 1976 and February 1993. 16 
patients with the diagnosis of EHE were treated 
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with OLT either at the University Health Sciences 
Center of Colorado ( 197Cr-1980) or at the University 
of Pittsburgh Medical Center (1981-1993). There 
were seven men and nine women. with ages ranging 
from 24 to 58 years (mean of 37 ;:!: 10.6 years). Fol-
low-up intervals ranged from I to 15 years (median 
of 4.5 years 1. 
Clinical features 
The frequency of symptoms is depicted in Table 
I. In five patients the tumor was found incidentally: 
in two patients during follow-up for previously 
treated cancer (squamous cell carcinoma of the na-
sopharynx and melanoma of the back), in one pa-
tient during evaluation of a back injury, in one pa-
tient during a laparotomy for endometriosis. and. 
finally. one patient discovered multiple lesions in 
her liver while performing an ultrasound examina-
tion on herself. Four of the nine women had taken 
oral contraceptives for indeterminate periods. No 
patient in this series had a history of exposure to 
hepatotoxins. 
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TABLE l. Clinical prese'lrQrion 
Frequency Mean duration 
Symptoms and signs (%1 (mos) 
Abdominal pain 56.2 12.5 
Weight loss 18.7 10 
Fatigue 6.5 2 
Anorexia 6.25 6 
Jaundice 12.5 9.5 
Ascites 6.25 12 
Shoulder pain 6.25 I 
Splenomegaly 6.25 24 
Dyspnea 6.25 2 
Cholangitis 6.25 I 
Hepatomegaly 25 7 
Incidental 3l.25 8 
Diagnosis 
In 14 patients the diagnosis was confirmed before 
transplantation: in seven by perc!ltaneous liver bi-
opsy and in seven by open liver biopsy. In the re-
maining two patients the diagnosis was obtained at 
the time of the transplant. 
Four patients had been misdiagnosed originally. 
In three cases. 1-5 years before transplant, the liver 
biopsies were interpreted as hemangiomas (and one 
of these patients had a separate biopsy interpreted 
as a sarcoma). One patient had a nondiagnostic per-
cutaneous biopsy. In one case the native liver also 
had unsuspected cirrhosis (the only case of cirrho-
sis associated with EHE in this series). 
The extent of the tumor was staged according to 
the pTNM classification (3.4). Fourteen patients 
were stage IY-A and two were stage IY-B. 
Treatment 
All patients underwent a standard orthotopic 
liver transplantation (S). The first patient in our se-
ries also had a concomitant excision of a pulmonary 
nodule. Five patients received chemotherapy with 
Adriamycin-based regimens: one preoperative. 
three postoperative. and in one case before and af-
ter the transplant. An additional :hree patients had 
radiotherapy. two preoperativel\' ::md one after sur-
gery. Baseline immunosuppression was accom-
plished with azathioprine and prednisone in one pa-
tient. with cyclosporine and prednisone in 10 pa-
tients and with FKS06 and prednisone in the 
remaining five patients. 
Statistical analysis 
Survival analysis was performed using the 
method of Kaplan-Meier. Differences between 
groups were tested for significance using Breslow's 
test. with the significance level set at O.OS. 
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RESULTS 
Actuarial patient survival at I. 3. and S years was 
100,85.7, and 71.3%. respectively (Fig. I). Nine of 
16 patients (6S9C) are alive and free of tumor; seven 
of these patients have had follow-up intervals >5 
years (median of7.5 years). Diffuse metastatic dis-
ease was responsible for death in five patients from 
16 months to 180 months after OL T (median: 43 
months). Two patients are alive with metastases: 
one with lung metastases 3 years after surgery, and 
the other with tumor in the liver ~ years after her 
transplant. This last patient was retransplanted but. 
unfortunately. there was residual tumor at the mar-
gins of the resection. 
Disease-free survival at 1. 3. and 5 years was 
81.3, 68.8. and 60.2%. respectively (Fig. 1). In-
volvement of the hilar lymph nodes or vascular in-
vasion was a frequent feature. being present in nine 
patients (S6.25'CL 01evertheless. half of those pa-
tients are currently alive and free of disease. There 
was no difference in the recurrence rates among 
patients with positive or negative nodes (Fig. 2). 
Likewise, vascular invasion did not affect the re-
currence rate (Fig. 3). The most common sites of 
recurrence were the liver. lung, and bone (Table 2). 
There were six postoperative complications that 
occurred in five patients. One patient bled from the 
Roux-en-Y loop. requiring exploration on the 4th 
postoperative day. Eight months later he developed 
a biliary stricture that required percutaneous dila-
tation. Two patients needed a second graft because 
of. primary nonfunction. at 2 and ~ days after trans-
plant, respectively. One patient required throm-
bectomy on the ~th postoperative day due to he-
patic artery thrombosis. Finally. one patient re-
ceived a second graft (for liver recurrence, 4 years 
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FIG.!. Actuarial and disease· free survival. 
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FIG. 2. Hilar lymph node status and recur.ence after transplan-
tation. 
after the primary transplant). and developed a bili-
ary leak and intraabdominal abscess. 10 and 14 days 
after her retransplant. respectively. She was finally 
discharged. after a prolonged hospital course. All 
patients recovered from their complications. 
DISCUSSION 
EHE is a soft-tissue malignant tumor that is char-
acterized by its epithelial-like appearance and vas-
cular endothelial histogenesis. It was histologically 
identified by Weiss and Enzinger in 1982 (1). and in 
1984 Ishak et al. first reported a series of 32 primary 
EHE of the liver (2). In 1988. we reported the first 
series of patients (10 cases) (6) with unresectable 
hepatic epithelioid hemangioendothelioma (HEHE) 
that were treated with liver transplantation. This 
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FIG. 3. Vascular invasion and recurrerKc~ ~iter transplantation. 
report updates that initial series. and adds an addi-
tional six cases that we have treated since. 
Liver transplantation for hepati.: malignancy re-
mains surrounded by controversy. stemming from 
the fact that hepatocellular carcinomas and cholan-
giocarcinomas are associated with a high recur-
rence rate after liver transplantation (7.8), 
The clinical presentation of HE HE is usually 
nonspecific. The true incidence of this tumor is not 
yet known, and it is possible that many of these 
tumors have been misdiagnosed. especially before 
Ishak's report in 1984 (9). The only risk factors 
known in these patients were the use of oral con-
traceptives (10). Often, a wedge biopsy of the tumor 
is necessary to recognize the architectural features 
such as the intravascular or intrasinusoidal growth 
pattern characteristic of the neoplasm (2.6.11). Im-
munohistological staining for Von Willebrand factor 
TABLE 2. Recurrence and survival 
Time to SUf\IVaJ 
Case no, Primary Age/seK~ Recurrence Site of recurrence recurrence (yrs)" tIme I yrsl" Outcome 
HEHE 28/F Yes Liver 1.1 15 DWT 
HEHE 50/M Yes Liva lung UII.5 ~I .: DWT 
HEHE 43/M Yes Lung 0,9 AWT 
4 HEHE 53/M Yes Bon~ lung 03,09 (.l DWT 
5 HEHE 381M Yes iiyD~r lung 2,311"+ ~ DWT 
6 HEHE 281M No :-; • .>. :-;A ~_P AWOT 
7 HEHE 281M No N .. \ kI~ ,- AWOT 
8 HEHE 41/F No :-; . .>. NA 6,) AWOT 
9 HEHE JI/F No NA NA 
-
AWOT 
1O HEHE 46/F Yes Li\'er 4 , AWT 
II HEHE 25/F Yes Livalung II 13 DWT 
12 HEHE 29/F No NA kK~ 6 AWOT 
13 HEHE 58/M No NA :-; • .>. U AWOT 
14 HE HE 33/F No NA N . .>. 10.5 AWOT 
15 HEHE 24/F No kK~ NA -3 AWOT 
16 HEHE 32JF No N . .>. NA - , AWOT 
--
HEHE. hepatic epithelioid hemangioendothelioma; A WOT. alive "ithout tumor; AWT, alive with tumor; DWT, died with tumor. 
" From day of transplant. 
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may also be of use in distinguishing the endothelial-
derived tumor cells from adenocarcinoma (2). Be-
cause of the variable cellularity within any given 
tumor nodule. needle biopsy may be nondiagnostic 
if only a fibrous tissue area is sampled. Relying on 
only the cytologic appearance may result in over-
grading the lesion as a highly malignant angiosarco-
ma. rather than a low-grade malignancy. This. ob-
viously _ could result in limiting the treatment plan 
to conservative medical management. excluding the 
possibility of a liver transplant. In point of fact. 4 of 
16 patients in the current series had an initial incor-
rect diagnosis. 
A direct comparison between the report of Ishak 
et al. (2) of 32 patients with HEHE and the current 
series of 16 patients treated with liver transplanta-
tion is not possible. However. it is interesting to 
note that only 9 of 32 (28%) of the Ishak et a!. pa-
tients without any specific therapy survived >5 
years. The actuarial survival rate of the HEHE pa-
tients treated with liver transplantation in the cur-
rent series (/1.3% at 5 years) is quite similar to that 
which we see in patients transplanted for nonmalig-
nant disease (12). The survival afier OLT for stage 
IY-A HEHE (n = f~F compares more than favor-
ably with that of hepatocellular carcinoma at the 
same stage (unpublished data. Fig. 4). 
Obviously. it remains difficult to propose a single 
standard therapeutic approach for these tumors be-
cause of their rarity and unpredic:able natural his-
lOry. According to Weiss and Enzinger (I). the his-
tologic features of HE HE do not predict tumor be-
havior. and consequently it is not possible to use 
the histologic characteristic of a given liver EHE as 
a guide for therapeutic decisions. Hepatic EHE is 
usually multifocal (1.2.6,11) and. therefore. not 
suitable for partial hepatectomy (6.13-16). The role 
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of chemotherapy without liver transplantation is un-
known because only a few cases have been pub-
lished in the literature (15.17); however, in our own 
series there was no response (data not shown). 
Thus. total hepatectomy and OlT is the surgical 
therapeutic procedure of choice. The long-term sur-
vival and disease-free survival after liver transplan-
tation reported in this article confirms the unique 
nature of this malignant tumor. Even after the de-
velopment of metastases. three patients survived 
for> 2 years. It is also interesting that in the subset 
of nine patients \liith vascular in\asion and positive 
hilar lymph nodes at transplant I findings that usu-
ally condemn to a rapid death from recurrence in all 
the other primary liver tumors). there were no mor-
talities and all of them are free of disease. Seven 
patients had recurrence. and five of them died as a 
result. The survivals were similar in patients with 
positive and negative nodes. We do not have suffi-
cient data to define a role for chemotherapy. radio-
therapy. or both in the treatment of this neoplasm. 
Thus. prospective studies will be required in this 
area. 
In conclusion. liver transplantation appears to be 
a very reasonable therapeutic approach for hepatic 
EHE when the tumor is not resectable (other than 
with a total hepatectomy). The long-term survival 
obtained in this series justifies li\t:!r transplantation 
for these tumors. even in the presence of limited 
extrahepatic disease. 
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